Our Business

We aspire to be a dynamic R&D organization that thinks, acts and interacts with the external world like no other. Our global team of researchers and scientists achieve this by harnessing cutting-edge science to push the boundaries of what is possible in order to bring transformative, life-changing therapies to patients worldwide. Hear some voices from our global R&D team and find out more about our therapeutic areas here.

Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

We are committed to bringing better health and a brighter future to patients by translating science into highly innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

Takeda believes access to healthcare and medicines should be universal. However, across the world, many people lack access to the services and treatment they need. We are expanding on our existing commitments to enhance global health so that patients in evolving healthcare systems can have access to our innovative and potentially life-saving medicines, even if their ability to pay for the full cost of treatment is limited. Details on how we do this through our Access to Medicines strategy can be found here.